Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Robin E. Gasiorowski"'
Autor:
Edward Abadir, Robin E. Gasiorowski, Kaitao Lai, Fiona Kupresanin, Adelina Romano, Pablo A. Silveira, Tsun‐Ho Lo, Phillip D. Fromm, Marina L. Kennerson, Harry J. Iland, P. Joy Ho, P. Mark Hogarth, Kenneth Bradstock, Derek N.J. Hart, Georgina J. Clark
Publikováno v:
Molecular Oncology, Vol 13, Iss 10, Pp 2107-2120 (2019)
Antibody‐based therapy in acute myeloid leukemia (AML) has been marred by significant hematologic toxicity due to targeting of both hematopoietic stem and progenitor cells (HSPCs). Achieving greater success with therapeutic antibodies requires care
Externí odkaz:
https://doaj.org/article/45bf9c7fc9c74c24a8afac22a249fba2
Autor:
Jennifer L. Hsu, Christian E. Bryant, Michael S. Papadimitrious, Benjamin Kong, Robin E. Gasiorowski, Daniel Orellana, Helen M. McGuire, Barbara Fazekas de St Groth, Douglas E. Joshua, P. Joy Ho, Stephen Larsen, Harry J. Iland, John Gibson, Georgina J. Clark, Phillip D. Fromm, Derek NJ Hart
Publikováno v:
OncoImmunology, Vol 7, Iss 4 (2018)
Only modest advances in AML therapy have occurred in the past decade and relapse due to residual disease remains the major challenge. The potential of the immune system to address this is evident in the success of allogeneic transplantation, however
Externí odkaz:
https://doaj.org/article/acfda01cb5dd4a4c8588ced75cab6370
Autor:
Tsun-Ho Lo, Edward Abadir, Robin E Gasiorowski, Karieshma Kabani, Murari Ramesh, Daniel Orellana, Phillip D Fromm, Fiona Kupresanin, Elizabeth Newman, Ilona Cunningham, Derek N J Hart, Pablo A Silveira, Georgina J Clark
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0216368 (2019)
Acute myeloid leukemia (AML) is the most common form of adult acute leukemia with ~20,000 new cases yearly. The disease develops in people of all ages, but is more prominent in the elderly, who due to limited treatment options, have poor overall surv
Externí odkaz:
https://doaj.org/article/75649774d1c04dbaafc3e41c4a7c1ba6